Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More »
Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More »
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals about active public health threats. This issue covers the period 12 to 18 April 2015, and includes updates on monitoring the 2014–2015 influenza season, the Ebola virus disease in... more
Pembrolizumab was superior to ipilimumab, the standard of care, as first-line therapy for advanced melanoma in the phase III KEYSTONE-006 trial.
Pemb... More »
ORLANDO – Depot medroxyprogesterone acetate (DMPA) given at a dose of 75 mg provided effective contraception with rates of weight gain and unschedul... More »
AT THE AAGP ANNUAL MEETING
NEW ORLEANS – Suicidal thoughts and actions are not rare among the elderly, and seem to have diverse drivers, including ... More »
Medicare is proposing to begin covering human papillomavirus testing once every 5 years in conjunction with the Pap smear test for its asymptomatic fe... More »
The second version of the Toronto Psoriatic Arthritis screen performed well at identifying psoriatic arthritis in 336 psoriasis patients, 131 psoriati... More »
The second version of the Toronto Psoriatic Arthritis screen performed well at identifying psoriatic arthritis in 336 psoriasis patients, 131 psoriati... More »
A $100 million study may decide the financial fate of amyloid PET imaging and thus potentially the frequency with which it is used to help rule out Al... More »